Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Significance of Immunohistochemical Expression of Wilms' Tumor 1 (WT1) in Colorectal Adenocarcinoma

NCT07778628 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT07778628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07778628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Significance of Immunohistochemical Expression of Wilms' Tumor 1 (WT1) in Colorectal Adenocarcinoma
Lead sponsor
Sohag University
Phase
Observational
Overall status
Completed
Start date
January 15, 2022
Completion date
June 30, 2026
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer